BI 11054
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 11054, covering 2014-10-24 to 2014-10-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 11054 CL Administered With the Respimat® in Healthy Male Volunteers [Phase 1]